Satellite Banner
Technology Networks Header
Thursday, July 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad Introduces ReadiLink Antibody Labeling Kits
Tuesday, March 11, 2014
ReadiLink antibody labeling kits are one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50–100 µg) of antibody.

Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

New HPLC Column Separates Challenging Glycan Isomers
Wednesday, March 05, 2014
Company will showcase the GlycanPac AXR-1 column at Pittcon 2014.

Malvern Instruments Shows NanoSight NTA at BioNanoMed 2014
Saturday, March 01, 2014
BioNanoMed 2014 to be held in Krems, Austria from 26 - 28 March.

Integromics Releases New Version of its qPCR Data Analysis Software
Friday, February 28, 2014
RealTime StatMiner® V5.0 software enhances functionality and improves customer experience.

New TouchTools™ PCR Wizard from Tecan
Wednesday, February 26, 2014
New tool aids automated PCR set-up and reduce training time and costs.

The Link Help Centre - Leading the Way in Customer Service
Saturday, February 08, 2014
Link Technologies invests in online support platform to serve the oligo community.

Exiqon Releases New Online Search Tool for Gene Expression Studies
Thursday, February 06, 2014
New version of miRSearch for rapid retrieval of detailed information about microRNA.

Wako Life Sciences Receives AACC Award
Tuesday, February 04, 2014
Dr. Shinji Satomura and Dr. Henry Wada receives the award for the uTASWako i30 Immunoanalyzer.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 704
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv